BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31499048)

  • 1. No prevention or cure of epilepsy as yet.
    Klein P; Tyrlikova I
    Neuropharmacology; 2020 May; 168():107762. PubMed ID: 31499048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoresistance - Epidemiology, mechanisms, and impact on epilepsy treatment.
    Janmohamed M; Brodie MJ; Kwan P
    Neuropharmacology; 2020 May; 168():107790. PubMed ID: 31560910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.
    Boison D; Rho JM
    Neuropharmacology; 2020 May; 167():107741. PubMed ID: 31419398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why we urgently need improved epilepsy therapies for adult patients.
    Billakota S; Devinsky O; Kim KW
    Neuropharmacology; 2020 Jun; 170():107855. PubMed ID: 31751547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feast and famine: Epilepsy treatment and treatment gaps in early 21st century.
    Löscher W; Klein P
    Neuropharmacology; 2020 Jun; 170():108055. PubMed ID: 32199986
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of the patient with medically refractory epilepsy.
    Granata T; Marchi N; Carlton E; Ghosh C; Gonzalez-Martinez J; Alexopoulos AV; Janigro D
    Expert Rev Neurother; 2009 Dec; 9(12):1791-802. PubMed ID: 19951138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying genetic epilepsies - Results from studies on tuberous sclerosis complex.
    Jozwiak S; Kotulska K; Wong M; Bebin M
    Neuropharmacology; 2020 Apr; 166():107908. PubMed ID: 31962286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of epilepsy: Should we be avoiding clinical trials?
    Klein P; Tyrlikova I
    Epilepsy Behav; 2017 Jul; 72():188-194. PubMed ID: 28647441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.
    Löscher W
    Neuropharmacology; 2020 May; 167():107605. PubMed ID: 30980836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The path from scientific discovery to cures for epilepsy.
    Carvill GL; Dulla CG; Lowenstein DH; Brooks-Kayal AR
    Neuropharmacology; 2020 May; 167():107702. PubMed ID: 31301334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting BDNF/TrkB pathways for preventing or suppressing epilepsy.
    Lin TW; Harward SC; Huang YZ; McNamara JO
    Neuropharmacology; 2020 May; 167():107734. PubMed ID: 31377199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
    Klein P; Friedman A; Hameed MQ; Kaminski RM; Bar-Klein G; Klitgaard H; Koepp M; Jozwiak S; Prince DA; Rotenberg A; Twyman R; Vezzani A; Wong M; Löscher W
    Epilepsia; 2020 Mar; 61(3):359-386. PubMed ID: 32196665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury.
    Eastman CL; D'Ambrosio R; Ganesh T
    Neuropharmacology; 2020 Aug; 172():107907. PubMed ID: 31837825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for epileptogenesis and its treatment.
    Engel J; Pitkänen A
    Neuropharmacology; 2020 May; 167():107735. PubMed ID: 31377200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Proof-of-Principle, Case-Control Study to Compensate for Potential Carbohydrates in Liquid Antiseizure Drugs in Children on the Ketogenic Diet.
    Haney CA; Charpentier A; Turner Z; Bessone SK; Doerrer SC; Kossoff EH
    J Child Neurol; 2019 Jun; 34(7):367-370. PubMed ID: 30782060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epileptogenesis, traumatic brain injury, and biomarkers.
    Engel J
    Neurobiol Dis; 2019 Mar; 123():3-7. PubMed ID: 29625256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-stroke epilepsy.
    Tanaka T; Ihara M
    Neurochem Int; 2017 Jul; 107():219-228. PubMed ID: 28202284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.
    Barker-Haliski M; Steve White H
    Neuropharmacology; 2020 May; 167():107750. PubMed ID: 31469995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of currently used antiseizure drugs.
    Sills GJ; Rogawski MA
    Neuropharmacology; 2020 May; 168():107966. PubMed ID: 32120063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells: A path towards improved epilepsy therapies.
    Lybrand ZR; Goswami S; Hsieh J
    Neuropharmacology; 2020 May; 168():107781. PubMed ID: 31539537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.